TMCJX
Price
$49.58
Change
-$0.31 (-0.62%)
Updated
Aug 15 closing price
Net Assets
5.47B
VIMSX
Price
$78.00
Change
-$0.19 (-0.24%)
Updated
Aug 15 closing price
Net Assets
196.76B
Interact to see
Advertisement

TMCJX vs VIMSX

Header iconTMCJX vs VIMSX Comparison
Open Charts TMCJX vs VIMSXBanner chart's image
Touchstone Mid Cap C
Price$49.58
Change-$0.31 (-0.62%)
VolumeN/A
Net Assets5.47B
Vanguard Mid Cap Index Investor
Price$78.00
Change-$0.19 (-0.24%)
VolumeN/A
Net Assets196.76B
TMCJX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TMCJX vs. VIMSX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMCJX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 197B vs. TMCJX (5.47B). VIMSX pays higher dividends than TMCJX: VIMSX (1.37) vs TMCJX (0.00). TMCJX was incepted earlier than VIMSX: TMCJX (18 years) vs VIMSX (27 years). TMCJX (1.91) is less costly to investors than VIMSX (0.17). TMCJX is a more actively managed with annual turnover of: 18.00 vs. VIMSX (16.00). TMCJX has a lower initial minimum investment than VIMSX: TMCJX (2500) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 14.59 vs. TMCJX (1.53). VIMSX return over 5 years is better than : 62.56 vs. TMCJX (36.78).
TMCJXVIMSXTMCJX / VIMSX
Total Expense Ratio1.910.171,124%
Annual Report Gross Expense Ratio1.910.171,124%
Fund Existence18 years27 years-
Gain YTD2.0458.55524%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.47B197B3%
Annual Yield % from dividends0.001.37-
Returns for 1 year1.5314.5910%
Returns for 3 years19.5526.7073%
Returns for 5 years36.7862.5659%
Returns for 10 years100.91125.6480%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROKU90.292.78
+3.18%
Roku
NNNN50.910.77
+1.54%
Anbio Biotechnology
ABOS1.420.02
+1.43%
Acumen Pharmaceuticals
KIDS19.190.06
+0.31%
OrthoPediatrics Corp
ASNS0.51-0.11
-17.94%
Actelis Networks